- NCIt
- C5028
Loading cancer entity…
Loading cancer entity…
Clinical trials
110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 | clinicaltrials |
| NCT00189293 | Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts | completed | Phase 4 | 128 | MEDA Pharma GmbH & Co. KGINDUSTRY | 1 | Feb 7, 2022 | clinicaltrials |
| NCT04620785 | Photodynamic Therapy in Treatment of Verrucae | unknown | N/A | 80 | Alexandria UniversityOTHER | 1 | Jul 26, 2021 | clinicaltrials |
| NCT04905030 | Education, Immigration and HPV Vaccination: an Informational Randomized Trial | unknown | N/A | 2,500 | Karolinska InstitutetOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT04796090 | Genital Wart and Sexuality in Adolescence | completed | — | 90 | Ankara City Hospital BilkentOTHER | 1 | Mar 15, 2021 | clinicaltrials |
| NCT03812510 | Safety Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 426 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Nov 23, 2020 | clinicaltrials |
| NCT03691831 | A Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 502 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Oct 27, 2020 | clinicaltrials |
| NCT03687372 | Study of A-101 Topical Solution for the Treatment of Common Warts | completed | Phase 3 | 503 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Oct 5, 2020 | clinicaltrials |
| NCT03183765 | Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts | completed | Phase 4 | 48 | Assiut UniversityOTHER | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04288817 | Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts | unknown | Phase 3 | 40 | Assiut UniversityOTHER | 0 | Feb 28, 2020 | clinicaltrials |
| NCT01796821 | Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) | completed | Phase 2 | 138 | G&E Herbal Biotechnology Co., LTDINDUSTRY | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03676101 | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 1 | 90 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT03158220 | Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) | completed | Phase 3 | 1,212 | Merck Sharp & Dohme LLCINDUSTRY | 6 | Nov 21, 2019 | clinicaltrials |
| NCT04073082 | Safety and Efficacy of Laser Therapy in Gynaecology | unknown | — | 300 | Juna d.o.o.INDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03948321 | Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts | unknown | N/A | 20 | Shanghai Dermatology HospitalOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT02188004 | The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases | completed | — | 4,691 | Jun ZhangOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT03210337 | A Phase2 of A-101 Topical Solution in Subjects With Common Warts | completed | Phase 2 | 157 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | May 1, 2019 | clinicaltrials |
| NCT03278028 | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | completed | Phase 2 | 159 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Apr 9, 2019 | clinicaltrials |
| NCT00543543 | Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) | completed | Phase 3 | 14,840 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT01047345 | A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) | completed | Phase 3 | 924 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT01651949 | Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) | completed | Phase 3 | 2,520 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT03625960 | Cantharone for the Treatment of Perenial Warts | completed | Phase 4 | 12 | Wayne State UniversityOTHER | 0 | Aug 10, 2018 | clinicaltrials |
| NCT01609530 | Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy | terminated | N/A | 31 | Trinity Health MichiganOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT03296397 | Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response(CONDYVAC) | unknown | Phase 3 | 300 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 27, 2018 | clinicaltrials |
| NCT01536834 | Safety & Performance Study of Verruca Treatment Device | completed | N/A | 35 | Reckitt Benckiser LLCINDUSTRY | 1 | Oct 11, 2017 | clinicaltrials |
| NCT02622568 | Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study | completed | Phase 4 | 28 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 8, 2017 | clinicaltrials |
| NCT03241680 | Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III) | unknown | N/A | 80 | Universidade do Vale do SapucaiOTHER | 1 | Aug 7, 2017 | clinicaltrials |
| NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | completed | Phase 1 | 16 | Neal D. Bhatia, MDOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT03153566 | Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients | unknown | Phase 3 | 45 | Assiut UniversityOTHER | 0 | May 17, 2017 | clinicaltrials |
| NCT00092482 | Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED) | completed | Phase 3 | 3,882 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 22, 2017 | clinicaltrials |
| NCT00517309 | Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)(FUTURE) | completed | Phase 3 | 1,877 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 22, 2017 | clinicaltrials |
| NCT01468636 | A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts | terminated | Phase 4 | 50 | University of British ColumbiaOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02115919 | Safety Study of Multikine in the Treatment of Perianal Warts | terminated | Phase 1 | 4 | United States Naval Medical Center, San DiegoFED | 1 | Aug 19, 2016 | clinicaltrials |
| NCT02558803 | HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 | completed | N/A | 1,305 | Regenstrief Institute, Inc.OTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT02551887 | HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts | completed | N/A | 647 | Regenstrief Institute, Inc.OTHER | 0 | Mar 11, 2016 | clinicaltrials |
| NCT02483455 | ALC-919 For The Treatment Of Common Warts | completed | Phase 2 | 21 | Veloce BioPharma LLCINDUSTRY | 1 | Mar 9, 2016 | clinicaltrials |
| NCT00851643 | Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) | completed | Phase 1 | 158 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 3, 2016 | clinicaltrials |
| NCT00520598 | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | completed | Phase 2 | 511 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 26, 2015 | clinicaltrials |
| NCT00092521 | Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) | completed | Phase 3 | 5,759 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 25, 2015 | clinicaltrials |
| NCT00551187 | A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) | completed | Phase 2 | 620 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2015 | clinicaltrials |
| NCT00501137 | A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine(BCGov-01) | completed | Phase 3 | 830 | Simon DobsonOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01639638 | Recurrent and Nonrecurrent Condyloma Treatment | terminated | Phase 2 / Phase 3 | 132 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Mar 12, 2015 | clinicaltrials |
| NCT00092495 | Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016) | completed | Phase 3 | 3,055 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 13, 2015 | clinicaltrials |
| NCT00862810 | Alternate Dosing Schedules Study for HPV Vaccine(ADS) | completed | Phase 4 | 72 | Duke UniversityOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02280642 | Alternate Dosing Schedules Study for HPV Vaccine (ADS)(ADS) | completed | — | 331 | Duke UniversityOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT02151630 | Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts | unknown | Phase 2 / Phase 3 | 60 | Isfahan University of Medical SciencesOTHER | 1 | May 30, 2014 | clinicaltrials |
| NCT01676792 | SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma | completed | Early Phase 1 | 29 | National Cheng-Kung University HospitalOTHER | 1 | Apr 22, 2014 | clinicaltrials |
| NCT01555112 | Safety and Efficacy Study to Test Topical AS101 for External Genital Warts | completed | Phase 1 / Phase 2 | 12 | BioMAS LtdINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT01553994 | Effectiveness Study of Gardasil on Condyloma | completed | — | 500,000 | Lisen Arnheim DahlstromOTHER | 1 | Mar 18, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Feb 25, 2022source: clinicaltrials